newsfilter
← Latest News
Business Wire·

BNB Plus Corp. Announces European Patent Grant for Fundamental Technology Underlying its Linea™ IVT Platform

Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform BNB Plus Corp. (NASDAQ:BNBX) ("BNBX" or the